PAVmed Inc. cotiza a 2.69 USD y tiene una capitalización bursátil de $22M. En los últimos 12 meses ha facturado $112000 con un margen de flujo de caja libre del -7376.1%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cel…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $-1.17 | $-1.05 |
| Estimado | $-0.66 | $-0.63 | $-0.69 | $-4.50 |
| Sorpresa | — | — | -69.6% | +76.7% |
| Métrica | PAVM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | -207.0% | 57.0% | -264.1% |
| Operating Margin | -30712.7% | -38.6% | -30674.1% |
| Net Margin | 564.8% | -33.6% | +598.3% |
| FCF Margin | -7376.1% | -13.9% | -7362.2% |
| ROE | 1.2% | -40.4% | +41.6% |
| ROA | 1.0% | -32.0% | +33.0% |
| Current Ratio | 0.17 | 2.84 | -2.67 |
| Debt / Equity | — | 0.28 | — |